Fatigue in Parkinson's disease: Motor or non-motor symptom?

Parkinsonism and Related Disorders

Volumn 19, Issue 2, 2013, Pages 148-152

  Fabbrini, G ^a,b   Latorre, A ^a   Suppa, A ^b   Bloise, M ^a   Frontoni, M ^a   Berardelli, A ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

Fatigue; Motor symptoms; Non motor symptoms; Parkinson's disease

Indexed keywords

LEVODOPA; PLACEBO;

CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; FATIGUE; HUMAN; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION;

FATIGUE; HUMANS; PARKINSON DISEASE;

EID: 84873737898     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.10.009     Document Type: Review

References (66)

1. Krupp L.B., LaRocca N.G., Muir-Nash J., Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46(10):1121-1123.
2. Chaudhuri A., Behan P.O. Fatigue and basal ganglia. J Neurol Sci 2000, 179:34-42.
3. Lou J.S., Kearns G., Oken B., Sexton G., Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord 2001, 16:190-196.
4. Friedman J.H., Brown R.G., Comella C., Garber C.E., Krupp L.B., Lou J.S., et al. Fatigue in Parkinson's disease: a review. Mov Disord 2007, 22:297-308. Working Group on Fatigue in Parkinson's Disease.
5. Marek T., Noworol G., Karwowski W. Mental fatigue at work and pain perception. Work Stress 1988, 2:133-137.
6. Swain M.G. Fatigue in chronic disease. Clin Sci 2000, 99:1-8.
7. Freal J.E., Draft G.H., Coryell J.K. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984, 65:135-138.
8. Krupp L.B., LaRocca N.G., Muir J., Steinberg A.D. A study of fatigue in systemic lupus erythematosus. J Rheumatol 1990, 17(11):1450-1452.
9. Irvine D.M., Vincent L., Bubela N., Thompson L., Graydon J. A critical appraisal of the research literature investigating fatigue in the individual with cancer. Cancer Nurs 1991, 14(4):188-199.
10. Irvine D., Vincent L., Graydon J.E., Bubela N., Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 1994, 17:367-378.
11. Van Hilten J.J., Weggeman M., van der Velde E.A., Kerkhof G.A., van Dijk J.G., Roos R.A. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1993, 5:235-244.
12. Diagnostic and statistical manual IV 1994, American Psychiatric Association, American Psychiatric Press, Washington, DC.
13. Tench C.M., McCurdie I., White P.D., D'Cruz D.P. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology 2000, 39(11):1249-1254.
14. Lerdal A., Celius E.G., Moum T. Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Mult Scler 2003, 9:509-514.
15. Da Costa D., Dritsa M., Ring A., Fitzcharles M.A. Mental health status and leisure-time physical activity contribute to fatigue intensity in patients with spondylarthropathy. Arthritis Rheum 2004, 51(6):1004-1008.
16. Treharne G.J., Kitas G.D., Lyons A.C., Booth D.A. Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors. J Health Psychol 2005, 10(3):457-474.
17. Tellez N., Rio J., Tintore M., Nos C., Galan I., Montalban X. Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?. Mult Scler 2005, 11(2):198-202.
18. Friedman J.H., Friedman H. Fatigue in Parkinson's disease. Neurology 1993, 43:2016-2018.
19. Karlsen K., Larsen J.P., Tandberg E., Jørgensen K. Fatigue in patients with Parkinson's disease. Mov Disord 1999, 14:237-241.
20. Shulman L.M., Taback R.L., Bean J., Weiner W.J. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001, 16:507-510.
21. Herlofson K., Larsen J.P. The influence of fatigue on health-related quality of life in patients with Parkinson's disease. Acta Neurol Scand 2003, 107:1-6.
22. Del Sorbo F., Albanese A. Management of pain and fatigue in Parkinson's disease. Parkinsonism Relat Disord 2012, 18(Suppl. 1):S233-S236.
23. Chaudhuri K.R., Healy D.G., Schapira A.H.V. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006, 5:235-245.
24. Barone P., Antonini A., Colosimo C., Marconi R., Morgante L., Avarello T.P., et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009, 24(11):1641-1649. PRIAMO Study Group.
25. Berardelli A., Conte A., Fabbrini G., Bologna M., Latorre A., Rocchi L., et al. Pathophysiology of pain and fatigue in Parkinson's disease. Parkinsonism Relat Disord 2012, 18(Suppl. 1):S226-S228.
26. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17(5):427-442.
27. Shulman L.M., Taback R.L., Rabinstein A.A., Shulman L.M., Taback R.L., Rabinstein A.A., et al. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002, 8:193-197.
28. Alves G., Wentzel-Larsen T., Larsen J.P. Is fatigue an independent and persistent symptom in patients with Parkinson's disease?. Neurology 2004, 63(10):1908-1911.
29. Hagell P., Brundin L. Towards an understanding of fatigue in Parkinson disease. J Neurol Neurosurg Psychiatr 2009, 80:489-492.
30. Miwa H., Miwa T. Fatigue in patients with Parkinson's disease: impact on quality of life. Intern Med 2011, 50(15):1553-1558.
31. Beiske A.G., Loge J.H., Hjermstad M.J., Svensson E. Fatigue in Parkinson's disease: prevalence and associated factors. Mov Disord 2010, 25(14):2456-2460.
32. Elbers R., van Wegen E.E., Rochester L., Hetherington V., Nieuwboer A., Willems A.M., et al. Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson's disease?. Mov Disord 2009, 24(10):1512-1518.
33. Garber C.E., Friedman J.H. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003, 60(7):1119-1124.
34. Schifitto G., Friedman J.H., Oakes D., Shulman L., Comella C.L., Marek K., et al. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology 2008, 71:481-485. Parkinson Study Group ELLDOPA Investigator.
35. Beiske A.G., Svensson E. Fatigue in Parkinson's disease: a short update. Acta Neurol Scand Suppl 2010, 190:78-81.
36. Van Hilten J.J., Hoogland G., van der Velde E.A., Middelkoop H.A., Kerkhof G.A., Roos R.A. Diurnal effects of motor activity and fatigue in Parkinson's disease. J Neurol Neurosurg 1993, 56(8):874-877.
37. Chou K.L., Persad C.C., Patil P.G. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord 2012, 18(5):510-513.
38. Friedman J.H., Alves G., Hagell P., Marinus J., Marsh L., Martinez-Martin P., et al. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord 2010, 25(7):805-822.
39. Smets E.M.A., Garssen B., Bonke B., de Haes J.C.J.M. The multi-dimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39:315-325.
40. Elbers R.G., van Wegen E.E., Verhoef J., Kwakkel G. Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson's disease. Parkinsonism Relat Disord 2012, 18(5):532-536.
41. Dooneief G., Mirabello E., Bell K., Marder K., Stern Y., Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 1992, 49:305-307.
42. Starkstein S.E., Mayberg H.S., Leiguarda R., Preziosi T.J., Robinson R.G. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatr 1992, 55:377-382.
43. Marsh L., McDonald W.M., Cummings J., Ravina B. Provisional diagnostic criteria for depression in Parkinson's Disease: report of an NINDS/NIMH Work Group. Mov Disord 2006, 21:148-158.
44. Havlikova E., Rosenberger J., Nagyova I., Middel B., Dubayova T., Gdovinova Z., et al. Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease. Parkinsonism Relat Disord 2008, 14(3):187-192.
45. Friedman J.H., Fernandez H.H. The nonmotor problems of Parkinson's disease. The Neurologist 2000, 6:8-27.
46. Friedman J.H., Friedman H. Fatigue in Parkinson's disease: a nine-year follow-up. Mov Disord 2001, 16(6):1120-1122.
47. Valko P.O., Waldvogel D., Weller M., Bassetti C.L., Held U., Baumann C.R. Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 2010, 17(12):1428-1436.
48. Nakamura T., Hirayama M., Hara T., Hama T., Watanabe H., Sobue G. Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease?. Mov Disord 2011, 26(10):1869-1874.
49. Goldstein D.S., Robertson D., Esler M., Straus S.E., Eisenhofer G. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 2002, 137:753-763.
50. Hwang W.J., Lin T.S. Evaluation of fatigue in Parkinson's disease patients with stimulated single fiber electromyography. Acta Neurol Scand 2001, 104:271-274.
51. Khedr E.M., Galal O., Said A., Abd-elsameea M., Rothwell J.C. Lack of post-exercise depression of corticospinal excitability in patients with Parkinson's disease. Eur J Neurol 2007, 14(7):793-796.
52. Ziv I., Avraham M., Michaelov Y., Djaldetti R., Dressler R., Zoldan J., et al. Enhanced fatigue during motor performance in patients with Parkinson's disease. Neurology 1998, 51:1583-1586.
53. Lou J.S., Kearns G., Benice T., Oken B., Sexton G., Nutt J. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Mov Disord 2003, 18:1108-1114.
54. Brasil-Neto J.P., Pascual-Leone A., Valls-Solé J., Cammarota A., Cohen L.G., Hallett M. Postexercise depression of motor evoked potentials: a measure of central nervous system fatigue. Exp Brain Res 1993, 93(1):181-184.
55. Brasil-Neto J.P., Cohen L.G., Hallett M. Central fatigue as revealed by post- exercise decrement of motor evoked potentials. Muscle Nerve 1994, 17:713-719.
56. Taylor J.L., Butler J.E., Allen G.M., Gandevia S.C. Changes in motor cortical excitability during human muscle fatigue. J Physiol 1996, 490:519-528.
57. Lou J.S., Benice T., Kearns G., Sexton G., Nutt J. Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson's disease. Clin Neurophysiol 2003, 114(5):930-937.
58. Benecke R., Rothwell J.C., Dick J.P., Day B.L., Marsden C.D. Disturbance of sequential movements in patients with Parkinson's disease. Brain 1987, 110(Part 2):361-379.
59. Agostino R., Berardelli A., Formica A., Accornero N., Manfredi M. Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia. Brain 1992, 115:1481-1495.
60. Berardelli A., Rothwell J.C., Thompson P.D., Hallett M. Pathophysiology of bradykinesia in Parkinson's disease. Brain 2001, 124:2131-2146.
61. Iansek R., Huxham F., McGinley J. The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait?. Mov Disord 2006, 21:1419-1424.
62. Berardelli A., Rona S., Inghilleri M., Manfredi M. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain 1996, 119(Part 1):71-77.
63. Kang S.Y., Wasaka T., Shamim E.A., Auh S., Ueki Y., Lopez G.J., et al. Characteristics of the sequence effect in Parkinson's disease. Mov Disord 2010, 25:2148-2155.
64. Pavese N., Metta V., Bose S.K., Chaudhuri K.R., Brooks D.J. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 2010, 133:3434-3443.
65. Markianos M., Koutsis G., Evangelopoulos M.E., Mandellos D., Karahalios G., Sfagos C. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis. J Neurochem 2009, 108:158-164.
66. Abe K., Takanashi M., Yanagihara T. Fatigue in patients with Parkinson's disease. Behav Neurol 2000, 12:103-106.